Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on SUEZ ENVIRONNEMENT CO. We currently have 7 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
SUEZ ENVIRONNEMENT CO
SUEZ ENVIRONNEMENT CO
H1 16: not great but Q2 is reassuring
28 Jul 16
Suez released H1 16 results. Revenues reached €7,455m (+2.2%, +2.7% lfl at CER), EBITDA €1,271m (-1.7%), EBIT €598m (-1%) and net income €174m (+23.7%). Net income increased over-propotionately with lower minority interests (buy-out of the Sembista minorities in Australia in H2 15). Net debt at the end of H1 was €8,765m (vs €8,363m in Q1 and €8,083m at year-end 2015) after the payment of the €545m dividend. The forex impact (top-line) was €-116m in H1 (€-43m in Q1).
Q1 16: a bit weak...
28 Apr 16
Suez Q1 16 results: revenues reached €3,555m (+0.5%), EBITDA €574m (-3.9%), EBIT €253m (-4.6%). Net debt at the end of Q1 16 was €8,363m (vs €8,083m in Q4 15). The group reiterated its targets for FY16, i.e. an organic growth in revenue of at least 2%, an over-proportionate growth in organic EBIT and a free cash flow of c. €1bn.
FY15 results unsurprising, no revolution going forward
24 Feb 16
Suez released FY15 results. Sales reached €15,135m (+5.7%), EBITDA €2,751m (+4.1%), EBIT €1,381m (+10.1%), net income €408m (-2%). Free cash flow reached €1,047m and net debt at year-end €8,083m. The dividend proposed is €0.65. The group’s targets are reiterated (organic growth of at least 2% in FY16, EBIT growth higher than top-line growth, FCF of c.€1bn and net debt/EBITDA of c.3x). Longer term, the group targets a €3bn EBITDA level in FY17.
Q3 15: in line; more needed for a real take-off
29 Oct 15
Suez released 9m results. These show revenues of €11,093m (+5.7% and +2.5% lfl at CER), EBITDA of €1,952m (+6.3% reported, +1.7% lfl at CER), and EBIT of €909m (+5% reported and +3.5% lfl at CER). Net debt at the end of Q3 stood at €7,918m (vs €8,024m after H1). The group reiterated its targets for FY15, i.e. revenue organic growth of at least 3%, positive EBITDA organic growth, EBIT organic growth of at least 4%, and a net financial debt/EBITDA ratio of c.3x.
H1 15 results: no real surprise
29 Jul 15
In H1 15, revenue was up +5.9% to €7,295m (+1.9% lfl at CER), EBITDA up +8% to €1,293m (+2%), and EBIT up +14.2% to €604m (+3.7%). The group has mainly benefited from forex and a (small) change in scope impact (+0.6% at the top-line level). Note profitability changes were adjusted for the capital gain on CEM in 2014 (€129m, accounted for at the EBITDA level). Net debt at the end of H1 was €8,024m, up from €7.7bn at the end of Q1 due to the dividend payment and forex.
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
16 Jan 17
We take a look at the rankings of the various countries in Africa that have a significant exposure to mining. We take the Transparency International corruption rankings as our starting point and modify these for exceptional geology and for current UK government travel warnings. Ghana, Botswana and Namibia come out as our top three, with Eritrea, Kenya and Zimbabwe at the bottom of our rankings.
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
N+1 Singer - St Ives - Downgrade
19 Jan 17
Marketing activation has been impacted by further decline in grocery retail impacting profit by c£5m. Strategic The Company is also taking this opportunity to revise its guidance for Strategic Marketing as its recovery pace is not running at the planned target rate. PBT falls from N1Se £31.9m to £25m. The Company expects dividend to be held based upon lowered guidance and the implied cash flow performance. There do not appear to be any covenant issues. Forecasts and TP under review and downgrade to Hold. We expect the shares to test the 100p level.
N+1 Singer - Northern lights - Shining prospects for 2017
16 Jan 17
As the birthplace of Stephenson, Armstrong and Swan, the North East of England has a proud history of industrial and technological innovation. Despite local economic challenges, the region’s industrial heritage lives on through continuing success in high end engineering and technology. The recent takeovers of private equity backed SMD (subsea robotics) and Nomad Digital (wi-fi on the railways) are testament to this. The North East has also emerged as a leader in genetics and genomics with an enviable life sciences and healthcare infrastructure. Against this backdrop, we expect the region to continue to throw up attractive IPO candidates to build on the six new listings in the past three years. We expect 2017 to be far kinder to the existing portfolio of North East plcs than 2016 (a year to forget) with recent management changes one important theme for the new year. Our top picks are Hargreaves Services, Quantum Pharma and Zytronic (all N+1 Singer Corporate clients) and we are Buyers of Northgate and Grainger.
N+1 Singer - Morning Song 19-01-2017
19 Jan 17
Actual Experience (ACT LN) 2017 – a milestone year for revenue | Bagir Group (BAGR LN) Independent NED appointment to strengthen Board composition | Bioquell (BQE LN) Reassuring pre-close statement | Carador Income Fund (CIFU LN) Q4 dividend increased to 2.75c, 0.5c higher than forecast | FreeAgent (FREE LN) Contract with Royal Bank of Scotland | Halfords Group (HFD LN) Excellent Q3 update, special divi and confidence in FX mitigations | N Brown Group (BWNG LN) Robust peak trading with reversal of drag from older titles | NCC Group (NCC LN) Interims confirm underlying business sound | St Ives (SIV LN) Downgrade | Summit Therapeutics (SUMM LN) Dr David Roblin appointed Chief Operating Officer and R&D President | Wilmington Group (WIL LN) Acquisition – Further scaling of Healthcare